Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Accounts Payables (2017 - 2025)

Historic Accounts Payables for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $36.6 million.

  • Inspire Medical Systems' Accounts Payables fell 548.5% to $36.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $36.6 million, marking a year-over-year decrease of 548.5%. This contributed to the annual value of $36.6 million for FY2025, which is 548.5% down from last year.
  • As of Q4 2025, Inspire Medical Systems' Accounts Payables stood at $36.6 million, which was down 548.5% from $59.2 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Accounts Payables registered a high of $59.2 million during Q3 2025, and its lowest value of $8.7 million during Q2 2021.
  • In the last 5 years, Inspire Medical Systems' Accounts Payables had a median value of $34.3 million in 2024 and averaged $30.2 million.
  • Per our database at Business Quant, Inspire Medical Systems' Accounts Payables soared by 14924.22% in 2023 and then tumbled by 3348.02% in 2025.
  • Inspire Medical Systems' Accounts Payables (Quarter) stood at $11.7 million in 2021, then surged by 130.15% to $26.8 million in 2022, then soared by 44.67% to $38.8 million in 2023, then decreased by 0.39% to $38.7 million in 2024, then dropped by 5.49% to $36.6 million in 2025.
  • Its Accounts Payables stands at $36.6 million for Q4 2025, versus $59.2 million for Q3 2025 and $53.2 million for Q2 2025.